CA2978476C - Preparation of lipemic plasma or serum samples for the determination of a lipid interference - Google Patents
Preparation of lipemic plasma or serum samples for the determination of a lipid interference Download PDFInfo
- Publication number
- CA2978476C CA2978476C CA2978476A CA2978476A CA2978476C CA 2978476 C CA2978476 C CA 2978476C CA 2978476 A CA2978476 A CA 2978476A CA 2978476 A CA2978476 A CA 2978476A CA 2978476 C CA2978476 C CA 2978476C
- Authority
- CA
- Canada
- Prior art keywords
- lipid
- plasma
- serum sample
- analyte
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16187839.2 | 2016-09-08 | ||
| EP16187839.2A EP3293521B1 (de) | 2016-09-08 | 2016-09-08 | Herstellung lipämischer plasma- oder serumproben für die bestimmung einer lipidinterferenz |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2978476A1 CA2978476A1 (en) | 2018-03-08 |
| CA2978476C true CA2978476C (en) | 2024-06-18 |
Family
ID=56936286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2978476A Active CA2978476C (en) | 2016-09-08 | 2017-09-06 | Preparation of lipemic plasma or serum samples for the determination of a lipid interference |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10488308B2 (OSRAM) |
| EP (1) | EP3293521B1 (OSRAM) |
| JP (1) | JP7022538B2 (OSRAM) |
| CN (1) | CN107807024B (OSRAM) |
| CA (1) | CA2978476C (OSRAM) |
| ES (1) | ES2720779T3 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113196064B (zh) * | 2019-01-29 | 2022-09-27 | 美国西门子医学诊断股份有限公司 | 降低血红蛋白A1c测定中的英脱利匹特/脂血干扰的浊度归一化算法和方法 |
| CN111929449A (zh) * | 2020-08-28 | 2020-11-13 | 保定天岳生物工程有限公司 | 一种aptt检测试剂盒 |
| EP4209234B1 (en) * | 2022-01-11 | 2026-03-25 | Fenwal, Inc. | Adjustment of target interface position in a centrifuge based on lipid concentration |
| CN116907961A (zh) * | 2023-06-27 | 2023-10-20 | 郴州市第一人民医院 | 一种消减脂血标本血脂干扰的方法 |
| CN119901692B (zh) * | 2023-10-28 | 2025-12-02 | 柏荣诊断产品（上海）有限公司 | 一种减弱脂血对透散射融合增强免疫比浊检测影响的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4977685A (OSRAM) * | 1972-11-29 | 1974-07-26 | ||
| DE4223355A1 (de) * | 1992-07-16 | 1994-01-20 | Boehringer Mannheim Gmbh | Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben |
| JP4273311B2 (ja) | 2002-04-26 | 2009-06-03 | 株式会社シノテスト | 試料中の測定対象物質の測定方法及び測定試薬 |
| CN101398422B (zh) * | 2008-10-28 | 2012-09-05 | 四川大学华西医院 | 高甘油三脂对血红蛋白浓度测定干扰的消除方法 |
| US20130084592A1 (en) | 2011-10-04 | 2013-04-04 | Siemens Healthcare Diagnostics Inc. | Methods for correcting assay measurements |
-
2016
- 2016-09-08 ES ES16187839T patent/ES2720779T3/es active Active
- 2016-09-08 EP EP16187839.2A patent/EP3293521B1/de active Active
-
2017
- 2017-09-05 CN CN201710789597.6A patent/CN107807024B/zh active Active
- 2017-09-06 CA CA2978476A patent/CA2978476C/en active Active
- 2017-09-07 JP JP2017171651A patent/JP7022538B2/ja active Active
- 2017-09-07 US US15/698,618 patent/US10488308B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107807024A (zh) | 2018-03-16 |
| ES2720779T3 (es) | 2019-07-24 |
| EP3293521A1 (de) | 2018-03-14 |
| CN107807024B (zh) | 2021-11-23 |
| US10488308B2 (en) | 2019-11-26 |
| CA2978476A1 (en) | 2018-03-08 |
| EP3293521B1 (de) | 2019-01-02 |
| JP2018040799A (ja) | 2018-03-15 |
| US20180067022A1 (en) | 2018-03-08 |
| JP7022538B2 (ja) | 2022-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10488308B2 (en) | Preparation of lipemic plasma or serum samples for the determination of a lipid interference | |
| Nikolac | Lipemia: causes, interference mechanisms, detection and management | |
| Patzke et al. | Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin | |
| JP6298043B2 (ja) | 自動分析計で流体試料中の被検体の量を測光法により決定するためのマルチアプリケーション法 | |
| Bairaktari et al. | Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels | |
| Guder et al. | The Haemolytic, Icteric and Lipemic Sample-Recommendations Regarding their Recognition and Prevention of Clinically Relevant Interferences | |
| Islam et al. | Methods of low-density lipoprotein-cholesterol measurement: analytical and clinical applications | |
| Lee et al. | A quick and large-scale density gradient subfractionation method for low density lipoproteins. | |
| KR102072251B1 (ko) | 혈액 샘플 분석 방법 | |
| NO162094B (no) | Fremgangsm te for bestemmelse av lavdensitetslipoprldl) og reagens for gjennomfoering av den. | |
| Yano et al. | Comparison of two homogeneous LDL-cholesterol assays using fresh hypertriglyceridemic serum and quantitative ultracentrifugation fractions | |
| US11156618B1 (en) | Rapid measurement of total vitamin D in blood | |
| Jialal et al. | Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation) | |
| WO2003083490A2 (en) | Method for predicting antiphospholid syndrome | |
| WO1996004556A1 (en) | Lipoprotein cholesterol assays | |
| Belcher et al. | A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. | |
| CN113884449B (zh) | 光度干扰确定 | |
| JP2011505866A (ja) | 脂質測定方法 | |
| US20130224777A1 (en) | Screening method for finding samples having antiphospholipid antibodies | |
| Luddington et al. | Lupus anticoagulant testing with optical end point automation | |
| WO2025111449A1 (en) | Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen | |
| Warnick et al. | Multilaboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates. | |
| JPS60501425A (ja) | 生物に由来する水溶液中のコロイド粒子の特異的除去の後に分析質を直接検出する方法及び試薬 | |
| Lopez et al. | Automated simultaneous turbidimetric determination of cholesterol in β-and pre-β-lipoproteins | |
| Mainard et al. | Are ‘precipitated LDL’really low density lipoproteins? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220901 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250827 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250827 |